Clinical Trial Update: Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry outlines a Phase 3 trial evaluating whether adding carboplatin chemotherapy to cabazitaxel improves outcomes compared with cabazit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Jevtana (cabazitaxel)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 3 | Status: RECRUITING